Ledger.Open graph →
SEC Form D · filed August 17, 2017

Apellis Pharmaceuticals, Inc

Offering
$60.1M
Sold
$20.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CRESTWOOD, KY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Nicholas R. Zelenczuk · Halifax, Z4ExecHoward Tullman · Chicago, ILExecGregory M. Friedman · ATLANTA, GAExec · DirectorKevin Allodi · Chicago, ILExecMathew M. Crosswy · ATLANTA, GAExec · DirectorRobert M. Woomer · ATLANTA, GAExec · DirectorSs Hotel Credit Opportunity Fund, LLC · ATLANTA, GAExec · DirectorDavid Dworsky · Gardena, CADirectorStorm Venture Associates V, L.L.C · MENLO PARK, CADirectorDominic A. Bassani · Crestone, CODirectorRyan R. Selwood · Halifax, Z4ExecPhilip C. Wolf · Montreal, Quebec, CanadaExecSophie Forest · Montreal, Quebec, CanadaExecBihua S. Chen · Crestwood, KYDirectorSteven S. Axon · Crestwood, KYExecRobert S. Adelman · Crestwood, KYDirectorMaha S. Katabi · Crestwood, KYDirectorRobert S. Kim · Crestwood, KYExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗